• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UPLC-MS/MS 法测定人血浆中直接凝血酶抑制剂达比加群的浓度

UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasma.

机构信息

Laboratory of Pharmacology and Toxicology, University Hospital, F-42055 Saint-Etienne, France.

出版信息

J Pharm Biomed Anal. 2012 Jan 25;58:152-6. doi: 10.1016/j.jpba.2011.09.018. Epub 2011 Sep 22.

DOI:10.1016/j.jpba.2011.09.018
PMID:21996066
Abstract

This article described the development and full validation of rapid and accurate liquid chromatography method, coupled with tandem mass spectrometry detection, for quantification of dabigatran in human plasma with [(13)C(6)]-dabigatran as internal standard. Plasma pretreatment involved a single step protein precipitation with methanol. Separation was performed by ultra performance reversed-phase chromatography on an Acquity UPLC BEH C8 100 mm × 1 mm × 1.7 μm column using a gradient elution mode. The mobile phase was a mix of distilled water containing 0.1% formic acid and methanol containing 0.1% formic acid. Specific multiple reaction monitoring transitions were recorded in positive electrospray ionization. The method was linear over the concentration range of 2-500 μg/L. The intra- and inter-day precision values were below 11.3% and accuracy was within 93.8% and 108.8% for all QC levels (5, 75 and 400 μg/L). The lower limit of quantification was 2 μg/L. Total analysis time was to 10 min including sample preparation.

摘要

本文描述了一种快速准确的液相色谱-串联质谱检测法的开发和全面验证,用于定量检测人血浆中的达比加群,内标物为 [(13)C(6)]-达比加群。血浆预处理采用甲醇单步蛋白沉淀法。采用 Acquity UPLC BEH C8 100mm×1mm×1.7μm 柱进行超高效反相色谱分离,采用梯度洗脱模式。流动相为含 0.1%甲酸的蒸馏水和含 0.1%甲酸的甲醇的混合物。在正电喷雾电离模式下记录特定的多重反应监测转换。该方法在 2-500μg/L 的浓度范围内呈线性。所有 QC 浓度(5、75 和 400μg/L)的日内和日间精密度值均低于 11.3%,准确度在 93.8%至 108.8%之间。定量下限为 2μg/L。包括样品制备在内,总分析时间为 10 分钟。

相似文献

1
UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasma.UPLC-MS/MS 法测定人血浆中直接凝血酶抑制剂达比加群的浓度
J Pharm Biomed Anal. 2012 Jan 25;58:152-6. doi: 10.1016/j.jpba.2011.09.018. Epub 2011 Sep 22.
2
HPLC MS/MS method for quantification of meprobamate in human plasma: application to 24/7 clinical toxicology.HPLC-MS/MS 法测定人血浆中甲丙氨酯的浓度:在 24/7 临床毒理学中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jan 15;879(2):215-8. doi: 10.1016/j.jchromb.2010.11.034. Epub 2010 Dec 4.
3
Quantitative determination of mitiglinide in human plasma by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.超高效液相色谱/电喷雾电离串联质谱法定量测定人血浆中的米格列奈
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jun 1;868(1-2):83-7. doi: 10.1016/j.jchromb.2008.04.037. Epub 2008 May 3.
4
Development and validation of an ultra performance liquid chromatography-tandem mass spectrometry method for the quantification of daptomycin in human plasma.建立并验证了一种超高效液相色谱-串联质谱法,用于定量检测人血浆中的达托霉素。
J Pharm Biomed Anal. 2011 Aug 25;56(1):78-85. doi: 10.1016/j.jpba.2011.04.019. Epub 2011 Apr 27.
5
Determination of lovastatin in human plasma by ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry and its application in a pharmacokinetic study.超高效液相色谱-电喷雾电离串联质谱法测定人血浆中洛伐他汀及其在药代动力学研究中的应用
J Pharm Biomed Anal. 2008 Mar 13;46(4):808-13. doi: 10.1016/j.jpba.2007.12.005. Epub 2007 Dec 8.
6
Determination of nimodipine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and pharmacokinetic application.超高效液相色谱-串联质谱法测定人血浆中尼莫地平及其药代动力学应用
J Pharm Biomed Anal. 2008 Feb 13;46(3):557-62. doi: 10.1016/j.jpba.2007.10.035. Epub 2007 Nov 9.
7
Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study.采用液相色谱/串联质谱法快速测定人血浆中阿哌沙班浓度及其在药代动力学研究中的应用。
J Pharm Biomed Anal. 2013 May 5;78-79:150-3. doi: 10.1016/j.jpba.2013.02.007. Epub 2013 Feb 20.
8
Determination of picropodophyllin and its isomer podophyllotoxin in human serum samples with electrospray ionization of hexylamine adducts by liquid chromatography-tandem mass spectrometry.采用电喷雾离子化-六亚甲基亚胺加合,通过液相色谱-串联质谱法测定人血清样品中的 picropodophyllin 及其异构体 podophyllotoxin。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 15;879(5-6):326-34. doi: 10.1016/j.jchromb.2010.12.017. Epub 2010 Dec 28.
9
Determination of palonosetron in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.采用超高效液相色谱-串联质谱法测定人血浆中帕洛诺司琼及其药代动力学研究。
J Pharm Biomed Anal. 2012 Jan 5;57:13-8. doi: 10.1016/j.jpba.2011.08.038. Epub 2011 Sep 1.
10
Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study.超高效液相色谱-串联质谱法测定人血浆中的拉西地平及其在药代动力学研究中的应用。
J Pharm Biomed Anal. 2008 Aug 5;47(4-5):923-8. doi: 10.1016/j.jpba.2008.04.018. Epub 2008 Apr 25.

引用本文的文献

1
Determination of Dabigatran Concentration in Human Plasma and Breast Milk.人血浆和母乳中达比加群浓度的测定。
Int J Anal Chem. 2021 Oct 22;2021:5949385. doi: 10.1155/2021/5949385. eCollection 2021.
2
Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.通过 LC-MS/MS 测定达比加群、利伐沙班和阿哌沙班的残留活性的 DOAC-Stop 程序评估。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619872556. doi: 10.1177/1076029619872556.
3
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review.
直接口服抗凝剂抗凝活性的实验室评估:一项系统评价
Chest. 2017 Jan;151(1):127-138. doi: 10.1016/j.chest.2016.08.1462. Epub 2016 Sep 13.
4
Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.评估显色抗凝血因子IIa检测法在门诊环境中评估老年房颤患者达比加群暴露情况的效果。
Thromb J. 2016 May 6;14:10. doi: 10.1186/s12959-016-0084-2. eCollection 2016.
5
UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays.用于测定人血浆中凝血抑制剂达比加群和利伐沙班的超高效液相色谱-多反应监测质谱法及其与功能测定法的比较
PLoS One. 2015 Dec 23;10(12):e0145478. doi: 10.1371/journal.pone.0145478. eCollection 2015.
6
Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C.基于肌酐和胱抑素C的血浆达比加群谷浓度与肾小球滤过率估计值之间的相关性。
Drugs R D. 2014 Jun;14(2):113-23. doi: 10.1007/s40268-014-0045-9.
7
Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.达比加群治疗的真实世界房颤患者的凝血检测与血浆纤维蛋白原浓度
Br J Clin Pharmacol. 2014 Sep;78(3):630-8. doi: 10.1111/bcp.12366.
8
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time.一项基于凝血酶时间指导房颤患者达比加群酯剂量调整的建议。
Br J Clin Pharmacol. 2014 Sep;78(3):599-609. doi: 10.1111/bcp.12364.
9
Concerns regarding the use of dabigatran for stroke prevention in atrial fibrillation.对达比加群酯用于房颤卒中预防的担忧。
Pharmaceuticals (Basel). 2012 Feb 3;5(2):155-68. doi: 10.3390/ph5020155.
10
Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism.基于常规液相色谱/三重四极杆质谱的代谢物鉴定和半定量估算方法在体外达比加群酯代谢研究中的应用。
Anal Bioanal Chem. 2013 Feb;405(5):1695-704. doi: 10.1007/s00216-012-6576-4. Epub 2012 Dec 14.